...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone.
【24h】

Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone.

机译:具有远端咪唑并喹啉酮的无环核苷类似物的结核分枝杆菌胸苷单磷酸激酶的设计,合成和抑制活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt) has been proposed as an attractive target in the search of new agents to fight against tuberculosis. We recently reported that thymine derivatives carrying a naphtholactam or naphthosultam moiety at position 4 of a (Z)-butenyl chain inhibit TMPKmt in the submuM range. Here we describe the replacement of the planar naphtholactam and naphthosultam rings in our identified hits by 5,6-dihydro-1H-imidazo[4,5,1-ij]quinolinones and a 5,6-dihydro-1H,4H-1,2,5-thiadiazolo[4,3,2-ij]quinoline-2,2-dioxide where the planarity has been broken. Interestingly, these non-planar compounds were similarly potent against the target enzyme than their aromatic analogues, suggesting a bioisosteric behavior that may also be applied to other biologically active compounds. The synthesis of the different targeted imidazoquinolinones has been successfully performed via a hypervalent iodide mediated oxidative cyclization of N-methoxyureas catalized by bis(trifluoroacetoxy)iodobenzene (PIFA) expanding the reported use of this reagent for the synthesis of differently substituted imidazoquinolinones.
机译:已经提出了来自结核分枝杆菌(TMPKmt)的胸苷单磷酸激酶作为寻找抗结核新药的有吸引力的靶标。我们最近报道,在(Z)-丁烯基链的4位带有萘甲酰胺或萘甲酰胺部分的胸腺嘧啶衍生物在submuM范围内抑制TMPKmt。在这里,我们描述了在我们确定的匹配数据中,用5,6-二氢-1H-咪唑并[4,5,1-ij]喹啉酮和5,6-二氢-1H,4H-1取代平面的萘环内酰胺和萘甲酰胺环, 2,5-噻二唑并[4,3,2-ij]喹啉-2,2-二氧化物的平面度已被破坏。有趣的是,这些非平面化合物与其芳香族类似物相比对靶酶的效价相似,表明其生物等排行为也可应用于其他生物活性化合物。已通过双(三氟乙酰氧基)碘苯(PIFA)催化的N-甲氧基脲的高价碘化物介导的氧化环化反应,成功地完成了不同目标咪唑基喹啉酮的合成,从而扩大了该试剂用于合成不同取代的咪唑基喹啉酮的报道用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号